Apical membrane receptors on intestinal M cells: Potential targets for vaccine delivery

Advanced Drug Delivery Reviews

Volumn 56, Issue 6, 2004, Pages 721-726

  Brayden, David J ^a   Baird, Alan W ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

M cells; Oral vaccine delivery; Peyer's patches

Indexed keywords

ANTIGENS; BIOSYNTHESIS; CELLS; DRUG DOSAGE; PATHOLOGY; VACCINES;

GENE EXPRESSION; LIGANDS; MIMIC PATHWAYS; PATHOGENS;

BIOLOGICAL MEMBRANES;

ANTIGEN; DNA VACCINE; MEMBRANE RECEPTOR; POLYGLACTIN; RECOMBINANT VACCINE; VACCINE;

APICAL MEMBRANE; BINDING SITE; CORRELATION ANALYSIS; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENTIATION; DRUG TARGETING; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL CULTURE; INTESTINE CELL; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; REVIEW; SCREENING TEST;

EID: 1942451816     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2003.10.036     Document Type: Note

References (45)

1. Shen W.-C. Oral peptide and protein delivery: unfulfilled promises. Drug Discov. Today. 8:2003;607-608.
2. Aungst B.J. Intestinal permeation enhancers. J. Pharm. Sci. 89:2000;429-442.
3. Haupt S., Rubinstein A. The colon as a possible target for orally administered peptide and protein drugs. Crit. Rev. Ther. Drug Carr. Syst. 19:2002;499-551.
4. Goldberg M., Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat. Rev., Drug Discov. 2:2003;289-295.
5. Modi P., Mihic M., Lewin A. The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist® System. Diabetes/Metab. Res. Rev. 18(Suppl. 1):2002;S38-S42.
6. Still J.G. Development of insulin progress and current status. Diabetes/Metab. Res. Rev. 18(Suppl. 1):2002;S29-S37.
7. Lambkin I., Pinilla C. Targeting approaches to oral delivery. Expert Opin. Biol. Ther. 2:2002;67-73.
8. Thanos C.G., Liu Z., Reineke J., Edwards E., Mathiowitz E. Improving relative bioavailability of dicoumarol by reducing particle size and adding the adhesive poly(fumaric-co-sebacic) anhydride. Pharm. Res. 20:2003;1093-1100.
9. Dyer A.M., Hinchcliffe M., Watts P., Castile J., Jabbal-Gill I., Nankervis R., Smith A., Illum L. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm. Res. 19:2002;998-1008.
10. Vajdy M., O'Hagan D.T. Microparticles for intranasal immunization. Adv. Drug Deliv. Rev. 51:2001;127-141.
11. Florence A.T. The oral absorption of micro- and nano-particulates - neither exceptional nor unusual. Pharm. Res. 14:1997;259-266.
12. Brayden D.J., Baird A.W. Microparticle vaccine approaches to stimulate mucosal immunization. Microbes Infect. 3:2001;867-876.
13. Pinto-Alphandary H., Aboubakar M., Jaillard D., Couvreur P., Vauthier C. Visualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats. Pharm. Res. 20:2003;1071-1084.
14. Delie F. Evaluation of nano- and microparticulate uptake by the gastrointestinal tract. Adv. Drug Deliv. Rev. 34:1998;221-233.
15. Eldridge J.H., Staas J.K., Meulbroek J.A., McGhee J.R., Tice T.R., Gilley R.M. Vaccine containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Adv. Exp. Med. Biol. 251:1989;191-202.
16. Tacket C.O., Reid R.H., Boedecker E.C., Losonsky G., Nataro J.P., Bhaghat H., Edelman R. Enteral immunization and challenge of volunteers given entertoxigenic E. coli CFA/II encapsulated in biodegradable microspheres. Vaccine. 12:1994;1270-1274.
17. Katz D.E., DeLorimier A.J., Wolf M.K., Hall E.R., Cassels F.J., van Hamont J.E., Newcomer R.L., Davachi M.A., Taylor D.N., McQueen C.E. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine. 21:2003;341-346.
18. Harokopakis E., Hajishengallis G., Michalek S.M. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system. Infect. Immun. 66:1998;4299-4304.
19. Frey A., Giannasca K.T., Welzin R., Giannasca P.J., Reggio H., Lencer W.I., Neutra M.R. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of epithelial cells: implications for microbial attachment and oral vaccine targeting. J. Exp. Med. 184:1996;1045-1059.
20. Clark M.A., Blair H., Liang L., Brey R.N., Brayden D., Hirst B.H. Targeting polymerized liposome vaccine carriers to intestinal M cells. Vaccine. 20:2002;208-217.
21. Lambkin I., Pinilla C., Hamashin C., Spindler L., Russell S., Schink A., Moya-Castro R., Allicotti G., Higgins L., Smith M., Dee J., Wilson C., Houghten R., O'Mahony D. Towards targeted oral vaccine delivery systems: selection of lectin mimetics from combinatorial libraries. Pharm. Res. 20:2003;1258-1266.
22. Giannasca P.J., Giannasca K.T., Leichtner A.M., Neutra M.R. Human intestinal M cells display the sialyl Lewis A antigen. Infect. Immun. 67:1999;946-953.
23. Lelouard H., Reggio H., Roy C., Sahuquet A., Mangeat P., Montcourrier P. Glycocalyx on rabbit intestinal M cells displays carbohydrate epitopes from Muc 2. Infect. Immun. 69:2001;1061-1071.
24. Lozniewski A., Haristoy X., Rasko D.A., Hatier R., Plenat F., Taylor D.E., Angioi-Duprez K. Influence of Lewis antigen expression by Helicobacter pylori on bacterial internalization by gastric epithelial cells. Infect. Immun. 71:2003;2902-2906.
25. Helander A., Silvey K.J., Mantis N.J., Hutchings A.B., Chandran K., Lucas W.T., Nibert M.L., Neutra M.R. The viral sigma-1 protein and glycoconjugates containing alpha-3-linked sialic acid are involved in Type 1 reovirus adherence to M cell apical surfaces. J. Virol. 77:2003;7964-7977.
26. Wu Y., Wang X., Csencsits K.L., Haddad A., Walters N., Pasqual D.W. M cell targeted DNA vaccination. Proc. Natl. Acad. Sci. U. S. A. 98:2001;9318-9323.
27. Tyler K.L., Clarke P., DeBiasi R.L., Kominsky D., Poggioli G.J. Reoviruses and the host cell. Trends Microbiol. 9:2001;560-564.
28. S. Kerneis, A. Bogdanova, J.-P. Kraehenbuhl, E. Pringault, Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 277, 949-952.
29. Gullberg E., Leonard M., Hopkins A., Karlsson J., Brayden D.J., Baird A.W., Artursson P. Expression of specific markers and particle transport in a new human intestinal M cell model. Biochem. Biophys. Res. Commun. 279:2000;808-813.
30. Fotopoulos G., Harari A., Michetti P., Trono D., Pantaleo G., Kraehenbuhl J.-P. Transepithelial transport of HIV-1 is M cell-mediated. PNAS USA. 99:2002;9410-9414.
31. Ouzilou L., Caliot E., Pelletier I., Prevost M.C., Pringault E., Colbere-Garapin F. Poliovirus transport through M-like cells. J. Gen. Virol. 83:2002;2177-2182.
32. Iwasaki A., Welker R., Mueller S., Linehan M., Nomoto A., Wimmer E. Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection. J. Infect. Dis. 186:2002;585-592.
33. Clark M.A., Hirst B.H., Jepson M.A. M-cell surface β 1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect. Immun. 66:1998;1237-1243.
34. Hussain N., Florence A.T. Utilizing bacterial mechanisms of entry: invasin-induced oral uptake of latex nanoparticles. Pharm. Res. 15:1998;153-156.
35. Schulte R., Kerneis S., Klinke S., Bartels H., Preger S., Kraehenbuhl J.-P., Pringault E., Autenrieth I.B. Translocation of Yersinia enterocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on M-like cells. Cell. Microbiol. 2:2000;173-185.
36. Tryer P., Faxwell A.R., Kyd J., Harvey M., Sizer P., Cripps A. Validation and quantitation of an in vitro M-cell model. Biochem. Biophys. Res. Commun. 299:2002;377-383.
37. Heppner F.L., Christ A.D., Klein M.A., Prinz M., Fried M., Kraehenbuhl J.-P., Aguzzi A. Transepithelial prion transport by M cells. Nat. Med. 7:2001;976-977.
38. Heggebo R., Gonzalez L., Press C.M., Gunnes G., Espenes A., Jeffrey M. Disease-associated PrP in the enteric nervous system of scrapie-affected Suffolk sheep. J. Gen. Virol. 84:2003;1327-1338.
39. Terry L.A., Marsh S., Ryder S.J., Hawkins S.A., Wells G.A., Spencer Y.I. Detection of disease-specific PrP in the distal ileum of cattle exposed orally to the agent of bovine spongiform encephalopathy. Vet. Rec. 152:2003;387-392.
40. Shmakov A.N., McLennan N.F., Kilshaw P.J., Ghosh S. Diverse patterns of expression of the 67-kF laminin receptor in the human small intestinal mucosa: potential binding sites for prion proteins. J. Pathol. 191:2000;318-322.
41. Lo D., Tynan W., Dickerson J., Mendy J., Chang H.-W., Scharf M., Byrne D., Brayden D., Higgins L., Evans C., O'Mahony D.J. Peptidoglycan recognition protein expression in mouse Peyer's patch follicle-associated epithelium suggests functional specialization. Cell. Immunol. 224:2003;8-16.
42. El-Bahi S., Caliot E., Bens M., Bogdanova A., Kerneis S., Kahn A., Vandewalle A., Pringault E. Lymphoepithelial interactions trigger specific regulation of gene expression in the M cell-containing follicle-associated epithelium of Peyer's patches. J. Immunol. 168:2002;3713-3720.
43. Lo D., Hilbush B., Mah S., Brayden D., Byrne D., Higgins L., O'Mahony D.J. Catching target receptors for drug and vaccine delivery using TOGA® gene expression profiling. Adv. Drug Del. Rev. 54:2002;1213-1223.
44. D. Lo, W. Tynan, J. Dickerson, M. Scharf, D. Byrne, D. Brayden, L. Higgins, C. Evans, D.J. O'Mahony, Identification of genes expressed specifically by follicle associated epithelium and M cells of mammalian Peyer's patch (submitted).
45. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.-P., Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:2001;61-367.